1-8 of 8
Nan Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Qian Cheng, JingWen Tan, Rui Liu, Liqing Kang, Hongjia Zhu, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Rong He, Xiaoyan Lou, Nan Xu, Wei Wang, Zhou Yu, Minghao Li, Hongfei Gu, Lei Yu, Xin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3447.
https://doi.org/10.1182/blood-2024-200516
Published: 2024
Journal Articles

Target Antigen-Expressing T Cells Facilitate CAR-T Cell Eradication of Residual CD19+ B Malignant Cells

Minghao Li, Wenjie Gong, JingWen Tan, Hongjia Zhu, Nan Xu, Liqing Kang, Xiaoyan Lou, Wei Wang, Jing Ye, Zhou Yu, Israth Jahan Tuhin, Liyun Chen, Chongsheng Qian, Meijing Liu, Ni Mei, Tong Shi, Guanghua Chen, Lei Yu, Shengli Xue, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4794.
https://doi.org/10.1182/blood-2024-206406
Published: 2024
Journal Articles

Phase I Open-Label Single-Arm Study of Sscart-19 in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in China

Liqing Kang, Shengli Xue, Xiaowen Tang, Xiaoyan Lou, Chongsheng Qian, Wenjie Gong, Mingzhu Xu, Haixia Zhou, Zhen Yao, Wei Wang, Minghao Li, Nan Xu, Zhou Yu, Suning Chen, Huiying Qiu, Haiping Dai, Yang Xu, Depei Wu, Lei Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3477.
https://doi.org/10.1182/blood-2023-181552
Published: 2023
Journal Articles

Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALL

Liqing Kang, Jinfeng Ma, Xiaoyan Lou, Xiaowen Tang, Shengli Xue, Suning Chen, Huiying Qiu, Miao Miao, Yue Han, Ying Wang, Aining Sun, Haiping Dai, Yang Xu, Limin Li, Shengjin Fan, Chongsheng Qian, Wenjie Gong, Mingzhu Xu, Haixia Zhou, Zhen Yao, Wei Wang, Minghao Li, Nan Xu, Zhou Yu, Depei Wu, Lei Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 889.
https://doi.org/10.1182/blood-2023-172615
Published: 2023
Journal Articles

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Kai Sun, Wen-Min Chen, Xu Wang, Xiao-Su Zhao, Ling-Di Li, Yue Hao, Jun Wang, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Qian Jiang, Xiao Jun Huang, Ya-Zhen Qin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11864–11865.
https://doi.org/10.1182/blood-2022-159866
Published: 2022
Journal Articles

CD20-Specific Chimeric Antigen Receptor-Expressing T Cells As Salvage Therapy in Rituximab-Refractory CD20(+) B-Cell Non-Hodgkin Lymphoma

Xin Li, Qian Cheng, Rui Liu, Liqing Kang, Nan Xu, Minghao Li, Lei Yu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2845.
https://doi.org/10.1182/blood-2021-150477
Published: 2021
Journal Articles

CD38-Directed CAR-T Cell Therapy: A Novel Immunotherapy Strategy for Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Xiaowen Tang, MD PhD, Depei Wu, MDPhD, Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Baoquan Song, Wei Cui, Jia Yin, Zheng Li, Lei Yu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-141602
Published: 2020
Journal Articles

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, MD, Jian Zhang, MD, Jia Chen, MD, Zhenkun Wang, PhD, Caixia Li, Fu Cheng Cheng, MD PhD, Depei Wu, MD PhD, Lei Yu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2621.
https://doi.org/10.1182/blood-2019-132067
Published: 2019